22.418 articles found

USE OF INTRAPUTAMINAL INFUSED GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR IN THE TREATMENT OF PARKINSON'S DISEASE IN HUMANS

GILL Steven S., GASH Donald M., GERHARDT Greg Allen.

· 2004-02-24

USE OF INTRAPUTAMINAL INFUSED GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR IN THE TREATMENT OF PARKINSON'S DISEASE IN HUMANS

GILL STEVEN S, GASH DONALD M, GERHARDT GREG ALLEN.

· 2004-02-24

USE OF INTRAPUTAMINAL INFUSED GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR IN THE TREATMENT OF PARKINSON'S DISEASE IN HUMANS

GILL STEVEN S, GASH DONALD M, GERHARDT GREG ALLEN.

· 2004-02-24

Use of intraputaminal infused glial cell-line derived neurotrophic factor in the treatment of Parkinson's disease in humans

GILL STEVEN S, GASH DONALD M, GERHARDT GREG ALLEN.

· 2004-02-24

COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE CONTAINING A CB1 RECEPTOR ANTAGONIST AND A PRODUCT THAT ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN.

JESUS BENAVIDES.

· 2004-02-23

ISOXAZOLOPYRIDINONES AND USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE.

SAMUEL HINTERMANN.

· 2004-02-13

Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.

Bezard E, Hill MP, Crossman AR, Brotchie JM, Michel A, Grimée R, Klitgaard H.

Eur J Pharmacol · 2004-02-01

DOI: 10.1016/j.ejphar.2003.11.065PMID: 14757136

Nonsurgical transthoracic epicardial ablation for the treatment of a resistant posteroseptal accessory pathway.

de Paola AA, Leite LR, Mesas CE.

Pacing Clin Electrophysiol · 2004-02-01

DOI: 10.1111/j.1540-8159.2004.00423.xPMID: 14764183

Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson's patients.

Stocchi F, Barbato L, Nordera G, Bolner A, Caraceni T.

J Neural Transm (Vienna) · 2004-02-01

DOI: 10.1007/s00702-003-0092-9PMID: 14767720

Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease.

Chen LW, Yung KK, Chan YS.

Curr Drug Targets · 2004-02-01

DOI: 10.2174/1389450043490596PMID: 15011953

[Surgical treatment for Parkinson's disease].

Guridi J, Rodríguez-Oroz MC, Manrique M.

Neurocirugia (Astur) · 2004-02-01

DOI: 10.1016/s1130-1473(04)70498-4PMID: 15039846

[Therapeutic study of autologous Schwann cells' bridge graft into the brain of hemiparkinsonian monkey].

Xu B, Jiang CC, Zhang L, Li BM, Chen ZP, Guan YH, Liu XD, Zhang FL.

Zhonghua Yi Xue Za Zhi · 2004-02-01

PMID: 15059517